— Know what they know.
Not Investment Advice
Also trades as: BIT.AX (ASX) · $vol 0M

BITRF OTC

Biotron Limited
1W: +2666.7% 1M: +3092.3% 3M: +1975.0% YTD: +266.3% 1Y: +219.2% 3Y: -15.3% 5Y: +80.4%
$0.02
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Buy · Power 64 · $19.4M mcap · 984M float · 0.012% daily turnover · Short 100% of daily vol

Balance Sheet Trends

Total Assets
$4M +280.8% ▲
5Y CAGR: -2.9%
Total Liabilities
$817K +90.6% ▲
5Y CAGR: +12.0%
Shareholders Equity
$3M +428.5% ▲
5Y CAGR: -5.5%
Cash & Investments
$2M +66.6% ▲
5Y CAGR: -18.1%
Total Debt
$0 +0.0% ▲
Net Debt
-$2M -66.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$2M$4M$393K$932K$2M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$2M$4M$393K$932K$2M
Net Receivables$0$0$0$0$18K
Inventory$0$0$0$0$0
Other Current Assets$0$23K$18K$7K$0
Total Current Assets$2M$4M$427K$955K$2M
Property, Plant & Equip.$90K$50K$13K$5K$3K
Goodwill & Intangibles$0$0$0$0$2M
Long-Term Investments$54K$0$0$0$21K
Other Non-Current Assets$0$54K$54K$20K$0
Total Non-Current Assets$144K$104K$67K$25K$2M
Total Assets$2M$4M$493K$980K$4M
— Liabilities —
Accounts Payable$311K$285K$286K$90K$50K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0-$49K$0$527K
Total Current Liabilities$751K$956K$738K$429K$817K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$20K$0$0$0$0
Total Non-Current Liabilities$63K$7K$0$0$0
Total Liabilities$814K$962K$738K$429K$817K
— Equity —
Common Stock$53M$57M$57M$59M$63M
Retained Earnings-$52M-$55M-$59M-$59M-$60M
Accumulated OCI$86K$20K$0$0$616K
Total Stockholders Equity$1M$3M-$244K$552K$3M
Total Liabilities & Equity$2M$4M$493K$980K$4M
— Key Metrics —
Total Debt$77K$45K$7K$0$0
Net Debt-$2M-$4M-$386K-$932K-$2M
Total Investments$54K$0$0$0$21K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms